Active Surveillance for Carbapenem-Resistant Enterobacteriaceae Using Stool Specimens Submitted for Testing for <i>Clostridium difficile</i>

David Banach, Jeannette Francois, Stephanie Blash, Gopi Patel, Stephen G. Jenkins, Vincent J. LaBombardi, Barry N. Kreiswirth, Arjun Srinivasan, David P. Calfee

Infection Control and Hospital Epidemiology · 2013 · 20 citations · 9 references

Concepts

Abstract

Active surveillance to identify asymptomatic carriers of carbapenem-resistant Enterobacteriaceae (CRE) is a recommended strategy for CRE control in healthcare facilities. Active surveillance using stool specimens tested for Clostridium difficile is a relatively low-cost strategy to detect CRE carriers. Further evaluation of this and other risk factor-based active surveillance strategies is warranted.

References

9